Search Results - "BRUNNER, H. R"

Refine Results
  1. 1

    Angiotensin II receptor antagonists by Burnier, M, Brunner, HR

    Published in The Lancet (British edition) (19-02-2000)
    “…Blockade of the renin-angiotensin system began as a way of studying the pathogenesis of cardiovascular disease with specific pharmacological probes. Oral…”
    Get full text
    Journal Article
  2. 2

    The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview by BRUNNER, H. R

    Published in Journal of human hypertension (01-05-2002)
    “…The new orally active angiotensin II (A II) type-1 receptor antagonist olmesartan medoxomil is a prodrug, which is rapidly converted in vivo to the active…”
    Get full text
    Conference Proceeding Journal Article
  3. 3

    Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects by Rossat, Julien, Maillard, Marc, Nussberger, Jürg, Brunner, Hans R., Burnier, Michel

    Published in Clinical pharmacology and therapeutics (01-07-1999)
    “…Purpose To compare the renal hemodynamic and tubular effects of celecoxib, a selective inhibitor of cyclooxygenase‐2 (COX‐2) to those of naproxen, a…”
    Get full text
    Journal Article
  4. 4

    Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor by Pedrazzini, Thierry, Seydoux, Josiane, Künstner, Pierre, Aubert, Jean-François, Grouzmann, Eric, Beermann, Friedrich, Brunner, Hans R

    Published in Nature medicine (01-06-1998)
    “…Neuropeptide Y (NPY) is a 36-amino-acid neurotransmitter which is widely distributed throughout the central and peripheral nervous system. NPY involvement has…”
    Get full text
    Journal Article
  5. 5

    Influence of Oscillatory and Unidirectional Flow Environments on the Expression of Endothelin and Nitric Oxide Synthase in Cultured Endothelial Cells by Ziegler, Thierry, Bouzourene, Karima, Harrison, Vanessa J, Brunner, Hans R, Hayoz, Daniel

    “…In vivo, endothelial cells (ECs) are subjected to a complex mechanical environment composed of shear stress, pressure, and circumferential stretch. The aim of…”
    Get full text
    Journal Article
  6. 6

    Increased Cardiac Angiotensin II Levels Induce Right and Left Ventricular Hypertrophy in Normotensive Mice by Mazzolai, Lucia, Pedrazzini, Thierry, Nicoud, Françoise, Gabbiani, Giulio, Brunner, Hans-R, Nussberger, Jürg

    Published in Hypertension (Dallas, Tex. 1979) (01-04-2000)
    “…Angiotensin II is a potent arterial vasoconstrictor and induces hypertension. Angiotensin II also exerts a trophic effect on cardiomyocytes in vitro. The goals…”
    Get full text
    Journal Article
  7. 7

    Blood Pressure-Independent Cardiac Hypertrophy Induced by Locally Activated Renin-Angiotensin System by Mazzolai, Lucia, Nussberger, Jurg, Aubert, Jean-Francois, Brunner, Dorette B, Gabbiani, Giulio, Brunner, Hans R, Pedrazzini, Thierry

    Published in Hypertension (Dallas, Tex. 1979) (01-06-1998)
    “…Cardiac hypertrophy is frequent in chronic hypertension. The renin-angiotensin system, via its effector angiotensin II (Ang II), regulates blood pressure and…”
    Get full text
    Journal Article
  8. 8

    Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers : inhibition of pressor response to exogenous angiotensin I and II by CHRISTEN, Y, WAEBER, B, NUSSBERGER, J, PORCHET, M, BORLAND, R. M, LEE, R. J, MAGGON, K, SHUM, L, TIMMERMANS, P. B. M. W. M, BRUNNER, H. R

    Published in Circulation (New York, N.Y.) (01-04-1991)
    “…The purpose of the present study was to assess the inhibitory effect of DuP 753, an orally active angiotensin II receptor antagonist, on the pressor action of…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetic and pharmacodynamic effects of YM087, a combined V1/V2 vasopressin receptor antagonist in normal subjects by BURNIER, M, FRICKER, A. F, HAYOZ, D, NUSSBERGER, J, BRUNNER, H. R

    Published in European journal of clinical pharmacology (01-11-1999)
    “…The pharmacokinetic and pharmacodynamic properties of YM087, (4'-[(2-methyl-1,4,5,6- tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)-carbonyl]-2-p henylbenzanilide…”
    Get full text
    Journal Article
  10. 10

    Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout by Würzner, Grégoire, Gerster, Jean-Charles, Chiolero, Arnaud, Maillard, Marc, Fallab-Stubi, Claire-Lise, Brunner, Hans R, Burnier, Michel

    Published in Journal of hypertension (01-10-2001)
    “…OBJECTIVE Losartan has been shown to increase urinary uric acid excretion and hence to lower serum uric acid levels. The purposes of the present study were(1)…”
    Get full text
    Journal Article
  11. 11

    Endothelial function in chronic congestive heart failure by Drexler, Helmut, Hayoz, Daniel, Münzel, Thomas, Hornig, Burckhardt, Just, Hanjörg, Brunner, Hans R., Zelis, Robert

    Published in The American journal of cardiology (15-06-1992)
    “…There is evidence that the endothelium plays an important role in the control of human vascular tone by releasing endothelium-derived nitric oxide. The…”
    Get full text
    Journal Article
  12. 12

    Calcineurin Blockade Prevents Cardiac Mitogen-activated Protein Kinase Activation and Hypertrophy in Renovascular Hypertension by Murat, Anastasia, Pellieux, Corinne, Brunner, Hans-R., Pedrazzini, Thierry

    Published in The Journal of biological chemistry (29-12-2000)
    “…Chronic stimulation of the renin-angiotensin system induces an elevation of blood pressure and the development of cardiac hypertrophy via the actions of its…”
    Get full text
    Journal Article
  13. 13

    The multifactorial nature of hypertension: the greatest challenge for its treatment? by Waeber, B, Brunner, H R

    Published in Journal of hypertension. Supplement (01-09-2001)
    “…Essential hypertension is a polygenic disease involving a major contribution of various environmental factors. It is therefore not surprising that…”
    Get more information
    Journal Article
  14. 14

    Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system by Zanchi, A, Schaad, N C, Osterheld, M C, Grouzmann, E, Nussberger, J, Brunner, H R, Waeber, B

    Published in The American journal of physiology (01-06-1995)
    “…This study was designed to assess the role of renin and of the sympathoadrenal system in the maintenance of the hypertension induced by chronic nitric oxide…”
    Get full text
    Journal Article
  15. 15

    Renal effects of angiotensin II receptor blockade in normotensive subjects by Burnier, Michel, Roch-Ramel, Françoise, Brunner, Hans R.

    Published in Kidney international (01-06-1996)
    “…Renal effects of angiotensin II receptor blockade in normotensive subjects. Several new non-peptide, orally active, angiotensin II receptor antagonists have…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Determinants of Angiotensin II Generation During Converting Enzyme Inhibition by Juillerat, Lucienne, Nussberger, Jürg, Ménard, Joël, Mooser, Vincent, Christen, Yves, Waeber, Bernard, Graf, Peter, Brunner, Hans R

    Published in Hypertension (Dallas, Tex. 1979) (01-11-1990)
    “…The reaction of the renin-angiotensin system to acute angiotensin converting enzyme inhibition was investigated in a single-blind, crossover study in nine…”
    Get full text
    Journal Article
  17. 17

    Confocal microscopy to analyze cytosolic and nuclear calcium in cultured vascular cells by Burnier, M, Centeno, G, Burki, E, Brunner, H R

    Published in The American journal of physiology (01-04-1994)
    “…With the development of calcium-sensitive fluorescent dyes and videomicroscopic imaging, several investigators have located the changes in intracellular…”
    Get full text
    Journal Article
  18. 18

    Compliance with Antihypertensive Therapy by Waeber, B., Burnier, M., Brunner, H. R.

    “…Poor compliance with antihypertensive therapy is a major cause of unsatisfactory blood pressure control. The doctor has a key role in all steps that lead the…”
    Get full text
    Journal Article
  19. 19

    Improved blood pressure control by monitoring compliance with antihypertensive therapy by Waeber, B, Vetter, W, Darioli, R, Keller, U, Brunner, H R

    “…Compliance with antihypertensive therapy was monitored for three months using an electronic medication dispenser in 35 patients remaining hypertensive despite…”
    Get more information
    Journal Article
  20. 20

    Isolated office hypertension: a prehypertensive state? by Bidlingmeyer, I, Burnier, M, Bidlingmeyer, M, Waeber, B, Brunner, H R

    Published in Journal of hypertension (01-03-1996)
    “…Isolated office hypertension, defined as hypertensive blood pressure values in a medical setting but normal self-measured or ambulatory-recorded blood…”
    Get more information
    Journal Article